UnitedHealth Group (UNH) Suffers a Larger Drop Than the General Market: Key Insights

In the latest close session, UnitedHealth Group (UNH) was down 2.39% at $339.58. The stock's performance was behind the S&P 500's daily loss of 0.13%. Meanwhile, the Dow experienced a drop of 0.27%, and the technology-dominated Nasdaq saw a decrease of 0.07%. Coming into today, shares of the largest U.S. health insurer had gained 12.77% in the past month. In that same time, the Medical sector gained 0.73%, while the S&P 500 gained 2.71%. Analysts and investors alike will be keeping a close eye on the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to go public on October 28, 2025. The company's upcoming EPS is projected at $2.87, signifying a 59.86% drop compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $113.54 billion, indicating a 12.61% upward movement from the same quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $16.21 per share and revenue of $448.87 billion, indicating changes of -41.4% and +12.14%, respectively, compared to the previous year. It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.34% lower within the past month. UnitedHealth Group is holding a Zacks Rank of #5 (Strong Sell) right now. Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 21.47. For comparison, its industry has an average Forward P/E of 16.21, which means UnitedHealth Group is trading at a premium to the group. Investors should also note that UNH has a PEG ratio of 2.25 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry had an average PEG ratio of 1.33 as trading concluded yesterday. The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 233, positioning it in the bottom 6% of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. 3 Stocks Poised to Lead the AI Software RaceThe software market is expected to witness a remarkable growth trajectory worldwide. Advancements in AI, increased demand for cybersecurity, and the rapid expansion of automation and robotics is offering investors an opportunity to unlock significant growth right now.Which software stocks will soar? Which will fizzle out? Find out in our urgent special report, Software is Eating the World. It examines where the software industry stands now and reveals three favorite software stocks to ownAccess the report free today >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks